Enjoy complimentary customisation on priority with our Enterprise License!
The travel vaccines market size is forecast to increase by USD 3.97 billion at a CAGR of 8.64% between 2023 and 2028. The market is experiencing significant growth due to several key factors. The rise in international vacations and medical tourism has led to an increase in the number of travelers, thereby driving demand for travel vaccines. Additionally, changes in the demographic profiles of travelers, such as an aging population and an increase in immunocompromised individuals, have heightened the need for protection against microbes and pathogenic organisms. Furthermore, the lack of comprehensive coverage for travel vaccines in health plans has created a gap in the market that vaccine manufacturers are looking to fill. Attaining immunity through vaccines is crucial for travelers to protect themselves from diseases while exploring new destinations.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Disease Type
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.